SU056

Research use only, not for human use.

SU056 is a YB-1 inhibitor that interacts with YB-1, inhibiting downstream proteins and pathways. It can induce cell-cycle arrest, apoptosis, and inhibit cell migration in ovarian cancer cells.

SU056 is a YB-1 inhibitor. SU056 induces cell-cycle arrest, apoptosis, and inhibits cell migration in ovarian cancer cells. SU056 interacts with YB-1 and inhibits and its associated downstream proteins and pathways. SU056 can enhance the cytotoxic effects of Paclitaxel (HY-B0015).

Cell Viability Assay Cell Line:OVCAR3/4/5/8, SKOV3 and ID8 cells Concentration:0-10 μM approximately Incubation Time:48 h Result:Inhibited cell growth with IC50 values of 1.27, 6.8, 4.33, 3.18, 1.73, 3.75 μM.Cell Migration Assay Cell Line:OVCAR8, SKOV3, and ID8 cells Concentration:0, 0.5, 1 μM Incubation Time:12 h Result:Dose-dependently inhibited cell migration.Western Blot Analysis Cell Line:OVCAR8 cell Concentration:1-5 μM Incubation Time:12 h Result:Dose-dependently inhibited the YB-1, TMSB10, SUMO2, and PMSB2 proteins.

Animal Model:C57BL/6 mice implanted (s.c.) with luciferase-expressing ID8 cells Dosage:20 mg/kg Administration:Intraperitoneal injection (i.p.)Result:Reduced the tumor weight by 2-fold, and is well-tolerated. Reduced the lung metastases. Inhibited YB-1 expression and downstream MDR1 (IHC assay of tumor sample).

——

Others

Other Targets

Others

——

——

2376580-08-2

369.34

C20H16FNO5

>98% (HPLC)

In Vitro:?DMSO : 50 mg/mL (135.38 mM; Ultrasonic )

OCCN1C2=C(C(c3cccc(F)c3)c3cc4OCOc4cc13)C(=O)OC2

——

(-20℃)

With Ice Pack

≥ 2 years